114 related articles for article (PubMed ID: 38583875)
1. Microwave hyperthermia enhances radiosensitization by decreasing DNA repair efficiency and inducing oxidative stress in PC3 prostatic adenocarcinoma cells.
Wu Y; Liu P; Chen W; Bai S; Chen S; Chen J; Xu X; Xia J; Wu Y; Lai J; Sun C; Lao Z; Wan X; Wu Z
Int J Hyperthermia; 2024; 41(1):2335201. PubMed ID: 38583875
[TBL] [Abstract][Full Text] [Related]
2. Redox-responsive nanoparticles enhance radiation therapy by altering multifaceted radio-resistance mechanisms in human castration-resistant prostate cancer cells and xenografts.
Lip H; Amini MA; Zetrini A; Cai P; Abbasi AZ; Bristow RG; Rauth AM; Wu XY
Radiother Oncol; 2022 May; 170():213-223. PubMed ID: 35227733
[TBL] [Abstract][Full Text] [Related]
3. Microwave hyperthermia promotes caspase‑3-dependent apoptosis and induces G2/M checkpoint arrest via the ATM pathway in non‑small cell lung cancer cells.
Zhao YY; Wu Q; Wu ZB; Zhang JJ; Zhu LC; Yang Y; Ma SL; Zhang SR
Int J Oncol; 2018 Aug; 53(2):539-550. PubMed ID: 29901106
[TBL] [Abstract][Full Text] [Related]
4. Mild hyperthermia as a localized radiosensitizer for deep-seated tumors: investigation in an orthotopic prostate cancer model in mice.
Cohen J; Anvari A; Samanta S; Poirier Y; Soman S; Alexander A; Ranjbar M; Pavlovic R; Zodda A; Jackson IL; Mahmood J; Vujaskovic Z; Sawant A
Br J Radiol; 2019 Mar; 92(1095):20180759. PubMed ID: 30673305
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG
Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic study of dual-function inhibitors targeting topoisomerase II and Rad51-mediated DNA repair pathway against castration-resistant prostate cancer.
Chiang YC; Leu WJ; Chen YC; Ye PC; Hsu YT; Hsiao YC; Hsu JL; Chan SH; Hsu LC; Huang HS; Guh JH
Prostate; 2023 Dec; 83(16):1549-1563. PubMed ID: 37583103
[TBL] [Abstract][Full Text] [Related]
7. Zerumbone Regulates DNA Repair Responding to Ionizing Radiation and Enhances Radiosensitivity of Human Prostatic Cancer Cells.
Chiang PK; Tsai WK; Chen M; Lin WR; Chow YC; Lee CC; Hsu JM; Chen YJ
Integr Cancer Ther; 2018 Jun; 17(2):292-298. PubMed ID: 28602099
[TBL] [Abstract][Full Text] [Related]
8. ThermomiR-377-3p-induced suppression of Cirbp expression is required for effective elimination of cancer cells and cancer stem-like cells by hyperthermia.
Lin TY; Jia JS; Luo WR; Lin XL; Xiao SJ; Yang J; Xia JW; Zhou C; Zhou ZH; Lin SJ; Li QW; Yang ZZ; Lei Y; Yang WQ; Shen HF; Huang SH; Wang SC; Chen LB; Yang YL; Xue SW; Li YL; Dai GQ; Zhou Y; Li YC; Wei F; Rong XX; Luo XJ; Zhao BX; Huang WH; Xiao D; Sun Y
J Exp Clin Cancer Res; 2024 Feb; 43(1):62. PubMed ID: 38419081
[TBL] [Abstract][Full Text] [Related]
9. Andrographolide sensitizes prostate cancer cells to TRAIL-induced apoptosis.
Wei RJ; Zhang XS; He DL
Asian J Androl; 2018; 20(2):200-204. PubMed ID: 28869219
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus E2F1 overexpression sensitizes LNCaP and PC3 prostate tumor cells to radiation in vivo.
Udayakumar TS; Stoyanova R; Hachem P; Ahmed MM; Pollack A
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):549-58. PubMed ID: 21195876
[TBL] [Abstract][Full Text] [Related]
11. MET inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways.
Zhou S; Dai Z; Wang L; Gao X; Yang L; Wang Z; Wang Q; Liu Z
J Cell Mol Med; 2021 Dec; 25(24):11157-11169. PubMed ID: 34761497
[TBL] [Abstract][Full Text] [Related]
12. Chalcone Derivatives Suppress Proliferation and Migration of Castration-resistant Prostate Cancer Cells Through FAK-mediated DNA Damage.
Xiao H; Wu Z; Wang Q; Zhou C; Lu F; Xiao Y
Anticancer Res; 2023 Jan; 43(1):389-403. PubMed ID: 36585202
[TBL] [Abstract][Full Text] [Related]
13. Ethanol promotes cytotoxic effects of tumor necrosis factor-related apoptosis-inducing ligand through induction of reactive oxygen species in prostate cancer cells.
Plante MK; Arscott WT; Folsom JB; Tighe SW; Dempsey RJ; Wesley UV
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):16-22. PubMed ID: 22986577
[TBL] [Abstract][Full Text] [Related]
14. NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer.
Chen Z; Jiang Q; Zhu P; Chen Y; Xie X; Du Z; Jiang L; Tang W
Prostate; 2019 Jan; 79(1):44-53. PubMed ID: 30178500
[TBL] [Abstract][Full Text] [Related]
15. Salicylate enhances the response of prostate cancer to radiotherapy.
Broadfield LA; Marcinko K; Tsakiridis E; Zacharidis PG; Villani L; Lally JSV; Menjolian G; Maharaj D; Mathurin T; Smoke M; Farrell T; Muti P; Steinberg GR; Tsakiridis T
Prostate; 2019 Apr; 79(5):489-497. PubMed ID: 30609074
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermia enhances radiosensitivity of colorectal cancer cells through ROS inducing autophagic cell death.
Ba MC; Long H; Wang S; Wu YB; Zhang BH; Yan ZF; Yu FH; Cui SZ
J Cell Biochem; 2018 Apr; 119(4):3763-3774. PubMed ID: 29240246
[TBL] [Abstract][Full Text] [Related]
17. [Microwave Hyperthermia Combined with Gemcitabine Inhibits Proliferation
and Induces Apoptosis of Human Lung Squamous Carcinoma Cells].
Yang Y; Zhao Y; Ma S; Yang D
Zhongguo Fei Ai Za Zhi; 2018 Nov; 21(11):805-814. PubMed ID: 30454541
[TBL] [Abstract][Full Text] [Related]
18. PLCε knockdown enhances the radiosensitivity of castration‑resistant prostate cancer via the AR/PARP1/DNA‑PKcs axis.
Pu J; Li T; Liu N; Luo C; Quan Z; Li L; Wu X
Oncol Rep; 2020 May; 43(5):1397-1412. PubMed ID: 32323799
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis.
Kelavkar UP; Nixon JB; Cohen C; Dillehay D; Eling TE; Badr KF
Carcinogenesis; 2001 Nov; 22(11):1765-73. PubMed ID: 11698337
[TBL] [Abstract][Full Text] [Related]
20. Targeting NPRL2 to enhance the efficacy of Olaparib in castration-resistant prostate cancer.
Chen X; Chen Z; Zheng B; Tang W
Biochem Biophys Res Commun; 2019 Jan; 508(2):620-625. PubMed ID: 30522863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]